Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Allogene Therapeutics, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$100 Billion
Q4 2024

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 253,576 shares of ALLO stock, worth $573,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,576

Previous 236,696 7.13%

Holding current value

$573,081

Previous $662,000 18.43%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$1.84 - $3.22 $31,059 - $54,353	16,880 Added 7.13%	253,576 $540,000
Q3 2024 Nov 07, 2024	SELL	$2.08 - $3.5 $19,215 - $32,333	-9,238 Reduced 3.76%	236,696 $662,000
Q2 2024 Aug 12, 2024	BUY	$2.23 - $4.38 $63,418 - $124,562	28,439 Added 13.08%	245,934 $573,000
Q1 2024 May 09, 2024	SELL	$2.92 - $5.63 $10,509 - $20,262	-3,599 Reduced 1.63%	217,495 $972,000
Q4 2023 Feb 08, 2024	BUY	$2.28 - $3.5 $84,658 - $129,958	37,131 Added 20.18%	221,094 $709,000
Q2 2023 Aug 09, 2023	BUY	$4.53 - $6.74 $84,190 - $125,262	18,585 Added 11.24%	183,963 $914,000
Q1 2023 May 08, 2023	BUY	$4.92 - $8.21 $9,510 - $15,869	1,933 Added 1.18%	165,378 $816,000
Q4 2022 Feb 07, 2023	SELL	$5.62 - $11.11 $49,332 - $97,523	-8,778 Reduced 5.1%	163,445 $1.03 Million
Q3 2022 Nov 01, 2022	BUY	$10.32 - $17.28 $4,963 - $8,311	481 Added 0.28%	172,223 $1.86 Million
Q2 2022 Aug 04, 2022	BUY	$6.78 - $12.28 $101,984 - $184,715	15,042 Added 9.6%	171,742 $1.96 Million
Q1 2022 May 09, 2022	BUY	$7.65 - $15.29 $14,336 - $28,653	1,874 Added 1.21%	156,700 $1.43 Million
Q4 2021 Feb 07, 2022	BUY	$13.13 - $24.52 $701,837 - $1.31 Million	53,453 Added 52.73%	154,826 $2.37 Million
Q2 2021 Aug 06, 2021	BUY	$23.49 - $35.8 $979,251 - $1.49 Million	41,688 Added 69.85%	101,373 $2.64 Million
Q1 2021 May 06, 2021	BUY	$25.79 - $39.02 $97,615 - $147,690	3,785 Added 6.77%	59,685 $2.11 Million
Q4 2020 Feb 09, 2021	BUY	$25.24 - $43.45 $635,719 - $1.09 Million	25,187 Added 82.01%	55,900 $1.41 Million
Q3 2020 Nov 10, 2020	BUY	$32.38 - $44.96 $368,031 - $511,015	11,366 Added 58.75%	30,713 $1.16 Million
Q2 2020 Aug 06, 2020	SELL	$18.39 - $54.04 $397,922 - $1.17 Million	-21,638 Reduced 52.79%	19,347 $828,000
Q1 2020 May 11, 2020	BUY	$18.22 - $28.25 $311,744 - $483,357	17,110 Added 71.66%	40,985 $797,000
Q4 2019 Feb 05, 2020	BUY	$24.82 - $31.4 $464,431 - $587,556	18,712 Added 362.42%	23,875 $620,000
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $25,953 - $32,792	994 Added 23.84%	5,163 $141,000
Q2 2019 Aug 08, 2019	BUY	$25.56 - $31.09 $106,559 - $129,614	4,169 New	4,169 $112,000

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $325M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Allogene Therapeutics, Inc. Transaction History